Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
Authors
Keywords
-
Journal
GUT
Volume 64, Issue 4, Pages 657-666
Publisher
BMJ
Online
2014-05-22
DOI
10.1136/gutjnl-2014-307138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
- (2011) M. Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Pigment Epithelium-Derived Factor Is an Intrinsic Antifibrosis Factor Targeting Hepatic Stellate Cells
- (2010) Tsung-Chuan Ho et al. AMERICAN JOURNAL OF PATHOLOGY
- Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis
- (2010) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
- (2010) Martin Hennenberg et al. LABORATORY INVESTIGATION
- Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy
- (2010) Binhui Wang et al. MICROVASCULAR RESEARCH
- Management of Varices and Variceal Hemorrhage in Cirrhosis
- (2010) Guadalupe Garcia-Tsao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pigment Epithelium-Derived Factor Inhibits Lysosomal Degradation of Bcl-xL and Apoptosis in HepG2 cells
- (2009) Takumi Kawaguchi et al. AMERICAN JOURNAL OF PATHOLOGY
- Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
- (2009) Kathrin Rychli et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Antiangiogenic therapy: Not just for cancer anymore?
- (2009) Vijay H. Shah et al. HEPATOLOGY
- Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor
- (2009) Adrien Bernard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Testing Molecular Therapies in Hepatocellular Carcinoma: The Need for Randomized Phase II Trials
- (2009) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiogenesis in liver disease
- (2009) Mercedes Fernández et al. JOURNAL OF HEPATOLOGY
- Portal Hypertension and Its Complications
- (2008) Arun J. Sanyal et al. GASTROENTEROLOGY
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
- (2008) Marc Mejias et al. HEPATOLOGY
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More